USPTO serial 79369271
Reviewed by CopyMark Law Group
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jeremy Peter Green Eche
Jeremy Peter Green Eche JPG Legal163 23rd St.Brooklyn, NY 11232United States| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Electromagnetic coils; electronic databases in the field of neuromodulation in neurological diseases recorded on computer media; downloadable computer software programs for patient profiling and neurological disease management; apparatus and instruments for research purposes, namely, electroencephalography (EEG) apparatus, neurostimulators and brain-computer interface (BCI) apparatus; electronic control instruments for influencing and interacting of the human brain; neural helmets, not for medical purposes; digital sensors for detecting brain waves and health parameters; downloadable artificial intelligence software for predicting and optimizing interventions and outcomes for neurological diseases; downloadable artificial intelligence software for use in the field of healthcare, namely, for predicting and optimizing interventions and outcomes for neurological diseases; downloadable artificial intelligence and machine learning software for predicting and optimizing interventions and outcomes for neurological diseases; downloadable artificial intelligence software for analysis of personal health and lifestyle data; downloadable software for the integration of artificial intelligence and machine learning in the field of Big Data | ACTIVE | — |
| 010 | Low-frequency electromagnetic therapy apparatus; transcutaneous electrical nerve stimulators; transcutaneous electrical nerve stimulation apparatus; diagnostic apparatus for medical purposes for testing neurological conditions; medical electrodes; medical instruments, namely, transcranial magnetic stimulation (TMS) apparatus, electroencephalography (EEG) apparatus, neurostimulators, brain-computer interface (BCI) apparatus; medical apparatus; testing apparatus for medical purposes; apparatus for analyzing brain wave frequencies; apparatus for the diagnosis of cerebrovascular diseases; brain pacemakers; transcutaneous electrical nerve stimulation electrodes; electrotherapy stimulation apparatus comprising electrical nerve stimulators; electrical apparatus for nerve stimulation for rehabilitative and pain management, disease modifying, stabilization and improvement in neurological and psychiatric conditions purposes; electronic nerve stimulators for medical use; apparatus for nerve location, namely, transcranial magnetic stimulation (TMS) apparatus; neural helmets for medical purposes; medical apparatus for neurographic purposes, namely, electroencephalography (EEG) apparatus; apparatus for the diagnosis of neurological diseases; medical apparatus and instruments relating to neurovegetative reactivity | ACTIVE | — |
| 042 | Data mining; development and testing of computing methods, algorithms and software; platform as a service (PAAS) services featuring software platforms for AI-optimized disease intervention, personalized disease predictability, patient profiling, and patient community services in neurological diseases; software as a service (SAAS) services featuring software for AI-optimized disease intervention, personalized disease predictability, patient profiling, and patient community services in neurological diseases; computer software development; research and development of new products; medical and scientific research, namely, conducting clinical trials for others; scientific research and development; scientific research for medical purposes in the field of neurological and psychiatric disorders; research in the field of artificial intelligence technology; platforms for artificial intelligence as software as a service (SAAS) services featuring computer software platforms for {AI-optimized disease intervention, personalized disease predictability, patient profiling, and patient community services in neurological diseases; medical research; technological research in the field of {neurological and psychiatric disorders; software as a service (SAAS) services featuring software for deep neural networks; software as a service (SAAS) services featuring software for machine learning, deep learning and deep neural networks | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 4, 2025 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 17, 2025 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Mar 17, 2025 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jan 8, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Oct 8, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Oct 8, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 23, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 23, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 3, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 20, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 20, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 20, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jun 20, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jun 20, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 17, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 17, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 17, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 6, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 12, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 12, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 28, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 27, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 2, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| May 16, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 12, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 11, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |